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Purpose: The primary objective of this work is to measure the secondary neutron field produced
by an uncollimated proton pencil beam impinging on different tissue-equivalent phantom materials
using organic scintillation detectors. Additionally, the Monte Carlo code -PoliMi was used to
simulate the detector response for comparison to the measured data. Comparison of the measured
and simulated data will validate this approach for monitoring secondary neutron dose during proton
therapy.
Methods: Proton beams of 155- and 200-MeV were used to irradiate a variety of phantom materials
and secondary particles were detected using organic liquid scintillators. These detectors are sensitive
to fast neutrons and gamma rays: pulse shape discrimination was used to classify each detected pulse
as either a neutron or a gamma ray. The -PoliMi code was used to simulate the secondary
neutron field produced during proton irradiation of the same tissue-equivalent phantom materials.
Results: An experiment was performed at the Loma Linda University Medical Center proton therapy
research beam line and corresponding models were created using the -PoliMi code. The
authors’ analysis showed agreement between the simulations and the measurements. The simulated
detector response can be used to validate the simulations of neutron and gamma doses on a particular
beam line with or without a phantom.
Conclusions: The authors have demonstrated a method of monitoring the neutron component of the
secondary radiation field produced by therapeutic protons. The method relies on direct detection
of secondary neutrons and gamma rays using organic scintillation detectors. These detectors are
sensitive over the full range of biologically relevant neutron energies above 0.5 MeV and allow
effective discrimination between neutron and photon dose. Because the detector system is portable,
the described system could be used in the future to evaluate secondary neutron and gamma doses
on various clinical beam lines for commissioning and prospective data collection in pediatric
patients treated with proton therapy. C 2016 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4963813]
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1. INTRODUCTION
Proton therapy facilities use high-energy protons in place
of the more traditional photons or electrons to treat cancer.
Protons are recognized for highly conformal dose distributions
that improve local tumor control while reducing normal
tissue toxicity by limiting unwanted dose. In theory, patients
treated with protons should have a drastically lowered risk for
radiation-induced secondary malignancies. However, there is
concern that high-energy neutrons produced from the inelastic
scattering of protons within the treatment head and within the
patient may reduce this benefit by depositing unwanted dose
outside of the target volume.
Because young patients are more sensitive to radiation,
and thus more likely to develop secondary malignancies
upon radiation exposure,1 proton therapy has been considered
superior to photon therapy in the treatment of pediatric
patients. The reduced dose to normal tissue offered by protons
would, in theory, reduce the number of secondary cancers
seen in pediatric patients. However, the presence of the
secondary radiation field, mostly due to secondary neutrons
and gamma rays, suggests that there may be an additional
small risk of secondary cancers that needs to be considered.
Additionally, a case study performed by Dorr and colleagues
determined that 50% of second malignancies occurred within
a 5 cm margin surrounding the treatment field, while less
than 10% of secondary malignancies occurred inside of the
field.2 Hence, it will be critical to evaluate the benefits of
proton therapy, specifically for pediatric cases, with carefully
designed prospective studies that include evaluation of the
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F. 1. Photograph of the experimental setup showing the two EJ-309 scintil-
lation detectors on the table with the associated shielding; a phantom block is
visible at the bottom of the picture. The proton beam direction is left-to-right.
secondary radiation field. Because of their relatively high
biological impact, the neutron component of the field is of
particular interest.
Rem-meters, often based on neutron moderation, generally
have low sensitivity to neutrons with energies greater than
15 MeV.3 Additionally, even advanced neutron dosimeters
underestimate doses from neutrons less than 2 MeV.4 Because
the biological effectiveness of neutrons is strongly dependent
on their energy, and because the energy spectrum of secondary
neutrons extends to the energy of the incident proton beam,
rem-meters are inadequate for neutron monitoring purposes
in this environment. Accurate neutron monitoring in a proton
therapy facility necessitates a detector that can perform
active, fast neutron spectroscopy up to energies of 250 MeV
and can discriminate between their neutrons and associated
gamma rays. Furthermore, the detectors used in this work are
sensitive to both neutrons and gamma rays, which can enable
monitoring of the dose from the complete secondary radiation
field.
From the patient perspective, the neutron dose deposited in
normal tissues is of primary importance. This dose is primarily
F. 2. Pulse shape discrimination results from a soft tissue phantom irradi-
ated with 200-MeV protons; the color bar is logarithmic.
from external neutrons produced in the treatment head as
well as internal neutrons produced in the patient. In practice,
secondary dose evaluation inside the patient is best done with
a Monte Carlo simulation combined with a digital phantom
used as a patient surrogate. Modern hybrid phantoms5 can be
deformed to create an age- and weight-adjusted model of a
specific patient that is matched to the partial patient anatomy
known from a planning CT scan of the patient. Previous studies
of secondary neutron doses have been performed with the
4 Monte Carlo code6,7 or the Monte Carlo code .8,9
It is important that correct implementation of these codes is
validated with experimental studies on clinical proton beam
lines.
The primary objective of this work is to measure the
secondary neutron field produced by an uncollimated proton
pencil beam impinging on different tissue-equivalent phantom
materials using organic scintillation detectors. Additionally,
the Monte Carlo code -PoliMi was used to simulate
F. 3. Measured neutron pulse height distributions for three phantom target materials irradiated with (a) 155-MeV and (b) 200-MeV protons.
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T I. The composition and density of the four CIRS, Inc., phantom materials used in the measurements taken
at Loma Linda University Medical Center. Material composition is given in weight percent.
Soft tissue 1.055 g/cm3 Trabecular bone 1.160 g/cm3 Compact bone 1.910 g/cm3
Hydrogen 8.47 6.99 3.30
Carbon 57.44 56.29 25.37
Nitrogen 1.65 2.03 0.91
Oxygen 24.59 22.72 35.28
Magnesium 7.62 3.36
Phosphorous 3.30 8.82
Chlorine 0.19 0.16 0.03
Calcium 8.49 22.91
the detector response for comparison to the measured data.
Comparison of the measured and simulated data was per-
formed to validate this approach for monitoring secondary
neutron dose during proton therapy.
2. DESCRIPTION OF THE EXPERIMENT
An experiment was performed at the Loma Linda Univer-
sity Medical Center proton therapy research beam line. Pulsed
proton beams with a cycle time of about 2 s and an active spill
length between 0.3 and 0.5 s were used to irradiate a variety of
radiation therapy phantoms at energies of 155 and 200 MeV;
the beam diameter was 2 cm at the exit of the vacuum tube
and approximately 4 cm at the entrance of the phantom blocks.
The beam current monitor in the research beam line was not
operational and no ion chamber was available, so the total dose
delivered to the blocks is unknown. The secondary particles
were detected using two 3-in. diameter by 3-in. thick EJ-309
organic liquid scintillators.10 These detectors are each sensitive
to fast neutrons and gamma rays. The signal from each
detector is independently collected with a fast photomultiplier
tube, with a time resolution of approximately 1.0 ns. Pulse
shape discrimination (PSD) was used to classify each detected
pulse as either a neutron or a gamma ray, which allows
selective analysis of the incident energy spectra. The PSD
algorithm relies on integration of the individual pulses from
the detectors; the integration range used for PSD determines
the effective dead time of the cells, in this case approximately
300 ns.
Four tissue-equivalent phantom materials manufactured
by Computerized Imaging Reference Systems (CIRS), Inc.,
Norfolk, VA were irradiated: compact bone, soft tissue,
plastic water, and trabecular bone. Each of the phantoms
was 30× 30 cm in the transverse dimension; the thickness
varied from 18 to 30 cm, but in each experiment was thick
enough to completely stop the proton beam. The proton
beams were aligned 5 cm from the detector-facing edge of
the phantom being irradiated. Irradiations were performed
for 20 min with 200-MeV beam and 30 min with the
155-MeV beam. Data were acquired using a digital mea-
surement system developed by the University of Michigan
Detection for Nuclear Nonproliferation Group based on a
CAEN DT5720 waveform digitizer (12 bit, 250 MHz).
Figure 1 shows a photograph of the experimental setup; the
beam direction is left-to-right. The detectors were located
70 cm from the target perpendicular to the beam line.
The two detectors were gain-matched using a 137Cs
source, aligning the Compton edge to 300 mV. A detection
threshold of 80 keV-electron-equivalent (keVee) was applied,
which is defined as the amount of scintillation light that is
emitted when a photon deposits 80 keV on an electron in
the scintillator. For neutrons, this threshold corresponds to
F. 4. The -PoliMi simulated spectrum of neutrons entering the detectors during irradiation of the CIRS, Inc., phantom materials with 155 MeV protons.
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F. 5. The -PoliMi simulated spectrum of neutrons entering the detectors during irradiation of the CIRS, Inc., phantom materials with 200 MeV protons.
approximately 600 keV of neutron energy deposited on a
proton.11
The neutron pulses were distinguished from the gamma-
ray pulses using an offline charge-integration method.12 The
raw detector pulses were integrated over two regions: the tail
region of the pulse and the total length of the pulse. The exact
ranges of these “tail” and “total” integrals were optimized for
each detector. Scintillation states excited by neutron scattering
are longer lived than states excited by photon scattering.
Consequently, detector pulses created by neutron events have
larger tail integrals for a given total integral. Figure 2 shows the
tail-integral versus total-integral projection of the soft tissue
irradiation, which is indicative of the other results because the
neutron and gamma-ray fields were all similar to one another.
Despite the large number of photons present in the measured
data, the neutron region is clearly separated from the photon
region. A second-order discrimination line was fit between
the two regions to discriminate the neutron and photon pulses:
for a given total integral, any pulse whose tail integral falls
above the discrimination line is called a neutron, and any
pulse whose tail integral falls below the discrimination line is
called a photon.
Figure 3 shows the resulting neutron pulse height distribu-
tions (PHDs) for the four phantom target materials irradiated
with 155-MeV and 200-MeV protons.
3. MONTE CARLO MODELING
The -PoliMi code was used to characterize the
secondary neutrons produced during proton irradiation of
biologically equivalent phantom materials. The code has the
ability to write a collision-log file containing all information
about the particle interactions inside of user-specified detector
cells. These data are used to calculate detector response
using a module-based postprocessing algorithm.13 The proton
transport was performed using the ENDF proton data libraries
included with the  code.14
The -PoliMi model was used to simulate the proton
irradiation experiment at the LLUMC experimental beam line.
The floor and walls in the experimental hall were neglected
in the model because they do not contribute significantly to
measured quantities, and to increase computational efficiency.
Table I lists the isotopic composition of the three CIRS, Inc.,
phantoms. Compact bone is the most-dense phantom material
at 1.910 g/cm3, followed by trabecular bone at 1.160 g/cm3
and soft tissue at 1.055 g/cm3.
The energy spectra of neutrons resulting from irradiation of
the four CIRS, Inc., phantom materials were simulated using
-PoliMi. Figures 4 and 5 show the energy spectrum
of neutrons entering the front faces of the two detectors upon
irradiation of the CIRS, Inc., phantoms with 155 and 200 MeV
T II. -PoliMi simulated fluences of neutrons incident on the front faces of the two detectors for the
different CIRS, Inc., phantom materials. Results are given as a ratio of neutrons incident on the front face of the




Neutrons incident on detector
front face per incident proton
Soft tissue
155 1.22 × 10−4
200 1.92 × 10−4
Trabecular bone
155 1.23 × 10−4
200 1.95 × 10−4
Compact bone
155 1.50 × 10−4
200 2.40 × 10−4
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F. 6. -PoliMi results show the proton (left) and neutron (right) flux distributions from 155-MeV protons interacting in a soft tissue phantom; the units
are protons (or neutrons) per cm2 per source proton.
protons, respectively. The shape of the neutron energy spectra
is similar between the different phantom materials, which
is consistent with the measured detector response shown in
Fig. 3.
Table II lists the integral sum of the neutron energy spectra
for all CIRS, Inc., phantom materials, the resulting value
being the total number of neutrons entering the detectors upon
irradiation of the phantom material with 155 or 200 MeV
protons. The neutron detector fluence was greater when
phantom materials were irradiated with 200 MeV protons
compared to 155 MeV. The fluence of neutrons on the detectors
was related to the density of the phantom material, with higher
neutron fluence produced from denser phantom materials.
Figure 6 shows the proton- and neutron-flux distributions
resulting from 155- and 200-MeV protons, interacting with
a soft tissue phantom; Fig. 7 shows the flux distributions for
the 200-MeV irradiation. These distributions were tallied in
the 1-cm thick plane with respect to the center of the beam
line. The proton distribution appears asymmetric because the
beam was incident near the edge of the target phantom;
protons that enter the air have a longer range than those
transporting purely through the phantom. The proton flux
distributions clearly show the Bragg peak at approximately
16 cm depth for 155 MeV and 25 cm depth for 200 MeV. The
secondary neutrons appear as an isotropic-like source emitted
from the target along the path of the beam. While the high-
energy neutrons are certainly forward-directed, the low-energy
neutrons are more isotropic; additionally, the scattering in the
phantom will also create an isotropic distribution.
Proton range and depth-dose characteristics within the
phantom materials were also evaluated using -PoliMi;
the results are shown for the CIRS, Inc., soft tissue phantom in
Fig. 8. The dose deposited by protons was tallied in volumetric
slices of the phantom using an  energy deposition tally.
The resulting distribution matches the Bragg peak shape, as
anticipated. The occurrence of the Bragg peak just beyond the
sharp drop in proton fluence is expected as a majority of a
proton dose is deposited at the end of its path.
The simulated ranges of protons in the four CIRS, Inc.,
phantom materials were compared to the continuous-slowing
down approximation (CSDA) range calculated using the






where RT is the CSDA range of a proton at a given energy
into a composite material T in units of g/cm2, Rref is the
known CSDA range in g/cm2 of a proton with the same energy
F. 7. -PoliMi results show the proton (left) and neutron (right) flux distributions from 200-MeV protons interacting in a soft tissue phantom; the units
are protons (or neutrons) per cm2 per source proton.
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F. 8. The -PoliMi simulated proton dose (solid lines) and fluence
(dotted lines) as a function of depth in the CIRS, Inc., soft tissue phantom
upon irradiation with 155 MeV (blue) and 200 MeV (red) protons.
into a reference material, and AT and Aref are the effective
atomic numbers of the composite material T and the reference













where Wi is the mass fraction of the ith element within the
composite material and Ai is the atomic number of that ith
element.15
Table III gives the required quantities for calculation
of proton CSDA ranges in the four CIRS, Inc., materials.
Reference materials were selected from those available in the
National Institute of Standards and Technology (NIST) 
database; selection was based on compositional similarity to
the CIRS, Inc., phantom materials. The ICRU compact bone
was chosen as the reference material for CIRS, Inc., compact
bone, A-150 tissue-equivalent plastic as the reference material
for CIRS, Inc., soft tissue and CIRS, Inc., trabecular bone,
and finally polymethyl methacrylate (PMMA) for CIRS, Inc.,
plastic water. Along with compositional data, CSDA ranges
of reference materials were gathered from the NIST 
database.16
Table IV gives the CSDA ranges of the CIRS, Inc., phantom
materials calculated using Eq. (2) along with the ranges
simulated using -PoliMi. Comparison gave good agree-
T IV. The CSDA ranges of protons in the four CIRS, Inc., phantom
materials with incident energy Ep were calculated with the Bragg-Kleeman
scaling rule given in Eq. (1). Reference materials were taken from those avail-
able in the NIST  database. The calculated CSDA range is compared to




energy (MeV) Calculated Simulated Difference (%)
Soft tissue
155 17.50 17.68 1.0
200 27.22 27.30 0.3
Trabecular bone
155 18.31 17.59 4.0
200 28.48 27.65 2.9
Compact bone
155 19.80 19.42 1.9
200 30.75 30.24 1.7
ment between the calculated and simulated ranges despite
the differences in atomic composition between CIRS, Inc.,
materials and the reference materials. The largest discrepancy
occurred between the calculated and simulated values in
trabecular bone, likely due to the lack of materials in the
NIST  database that had composition and density similar
to those of the CIRS, Inc., trabecular bone phantom.
Figures 9 and 10 show the -PoliMi simulated
fluence map of neutrons within different energy groups upon
irradiation of the CIRS, Inc., soft tissue phantom with 155 and
200 MeV protons, respectively. Secondary neutrons between 0
and 5 MeV are emitted isotropically, while those above 5 MeV
are more forward directed. Thus, the secondary neutron field
can be separated into two distinct components; the isotropic,
low-energy component and the forward-directed, high-energy
component.
The biological effectiveness of neutron radiation peaks
at energies of 1 MeV,17 suggesting that the majority of the
biologically weighted dose from secondary neutrons arises
from the low-energy component of the secondary neutron
field. It is evident from Figs. 9 and 10 that this dose will
primarily be deposited within the patient.
4. COMPARISON OF MEASURED
AND SIMULATED DATA
Tallies in the standard  code calculate average energy
deposition with linear response functions; however, the
response of organic scintillators is nonlinear and depends
on the exact details of the neutron collision history in the








number 155 MeV 200 MeV
A-150 tissue-equivalent plastic 1.127 4.73 16.56 25.75
Polymethyl methacrylate 1.190 5.20 17.14 26.64
ICRU compact bone 1.850 6.76 17.94 27.86
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F. 9. -PoliMi simulation of the fluence of neutrons with energy En resulting from the CIRS soft tissue phantom irradiated with 155 MeV protons, given
in neutrons per cm2 per incident proton.
detector.18 The response of the EJ-309 scintillators was
calculated using the MPPost code,19 which is a detec-
tion postprocessor distributed with the -PoliMi code.
Figure 11 shows the total simulated and measured neutron
pulse height distribution from the EJ-309 scintillators. One
should note that the measured distributions were arbitrarily
scaled because the absolute proton fluence was not monitored
during the experiment.
The pulse height distributions from the detectors can be
converted into dose rate by inverting the known detector
response functions.20 The detector response functions have
been measured and previously published in Ref. 11. The
energy deposited in the detector is converted to dose deposited
(in gray) by dividing by the mass of each detector cell. This
dose is then converted to dose equivalent with the ICRP-
21 energy-dependent radiation weighting factors.17 Table V
summarizes the dose rates for each of the phantom materials
and proton beam energies. For comparison,  (Ref. 14)
point-detectors tallies with an ICRP-21 dose modifier are used
to calculate neutron dose equivalent directly from simulated
protons; for these calculations, all neutrons above the detection
threshold were tallies. As expected, the dose rates unfolded
from the detector response slightly under-predict the 
calculations due to the limited sensitivity of our detection
system to high-energy neutrons. These results show that the
neutron dose rates at the detector position will reach significant
levels at expected proton clinical intensities, which may be on
the order of 1010–1011 s−1.
5. SUMMARY AND DISCUSSION
Organic scintillators detect incident fast neutrons primarily
through elastic scattering on hydrogen nuclei: neutrons with
energy less than a few hundred keV cannot deposit sufficient
energy to create a detectable pulse. For the experimental
configuration considered in this work, approximately 37% of
neutrons incident on the detectors have energy below 600 keV
and thus cannot be detected. This energy spectrum is related
to the detector placement relative to the target block and self-
attenuation of the neutrons within the target block, as well as
neutron scattered through the sides and back of the detector
assembly. We are currently investigating analysis techniques
to enable data acquisition at lower detection thresholds, down
to approximately 100 keV. A thermal detection medium such
as 6Li glass could be incorporated into the detection system to
increase sensitivity to lower energy neutrons.
The neutrons produced by such high-energy protons will
also be quite high in energy; in fact, they can take any energy
up to the initial proton energy; approximately 6% of the
neutrons incident on the detector are above 20 MeV. Because
the elastic scattering cross section decreases as neutron energy
increases, it is important to investigate the overall detection
efficiency of the high-energy neutrons. Figure 12 shows the
simulated energy spectrum of the neutrons incident on the
detector face for 200-MeV proton irradiation of the soft tissue
target, as well as the portion of this incident spectrum that
is detected. As expected, the detection efficiency decreases
F. 10. -PoliMi simulation of the fluence of neutrons with energy En resulting from the CIRS, Inc., soft tissue phantom irradiated with 200 MeV protons,
given in neutrons per cm2 per incident proton.
Medical Physics, Vol. 43, No. 11, November 2016
5922 Clarke et al.: A scintillator-based approach to monitor secondary neutron production during proton therapy 5922
F. 11. -PoliMi simulated and measured neutron pulse height distributions from 155- and 200-MeV irradiation of the CIRS, Inc., phantom materials (a)
soft tissue; (b) trabecular bone; (c) and compact bone phantoms. Measured PHDs were arbitrarily scaled for comparison.
as the incident neutron energy increases; Fig. 12(b) shows
the energy-dependent intrinsic neutron detection efficiency.
The error bars on the plot are only statistical; uncertainties in
the nuclear data particularly at high energies could contribute
to the observed fluctuations. The overall intrinsic detection
efficiency is approximately 15%; however, if one considers
only the portion of the incident spectrum that is above the
detection threshold, the intrinsic efficiency is approximately
T V. Dose rates at the detector positions calculated using a  point detector tally as well as deconvolved









155 1.58 × 10−7 2.71 × 10−7
200 2.41 × 10−7 4.62 × 10−7
Trabecular bone
155 1.66 × 10−7 2.66 × 10−7
200 2.52 × 10−7 4.58 × 10−7
Compact bone
155 2.17 × 10−7 3.10 × 10−7
200 3.27 × 10−7 5.37 × 10−7
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F. 12. (a) Simulated energy spectrum of incident and detected neutrons for 200-MeV proton irradiation of the soft tissue target; (b) energy dependent neutron
detection efficiency.
22%. Furthermore, the radiation weighting factor peaks near
1 MeV and begins to quickly decrease for higher energies.
6. CONCLUSIONS
We have demonstrated a method of monitoring the neutron
component of the secondary radiation field produced by
therapeutic protons. The method relies on direct detection of
secondary neutrons and gamma rays using organic scintillation
detectors. These detectors are sensitive over the full range of
biologically relevant neutron energies above 0.5 MeV and
allow effective discrimination between neutron and photon
dose.
An experiment was performed at the Loma Linda Univer-
sity Medical Center proton therapy research beam line and
corresponding models were created using the -PoliMi
code. Our analysis showed agreement between the shape of
the simulated and measured detector response. Once fully
validated, simulated detector response can be used to assess
neutron dose on a particular beam line without the need for
experiments. Because the detector system is portable and
sensitive to neutrons and gamma rays, the described system
could be used in the future to evaluate secondary doses on
various clinical beam lines for commissioning and prospective
data collection in pediatric patients treated with proton therapy.
Future work will focus on absolute validation of the simulation
models as well as deconvolving the detector response to
produce absolute dose rate measurements for neutrons, as well
as photons in a single instrument.
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